Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Meihua International Medical Technologies Co Debt-to-Equity?
Meihua International Medical Technologies CoMHUAF 59 Debt-to-Equity is 0.05 as of Dec. 2025, which is at its 10-year median of 0.05. GuruFocus rates MHUAF with a GF Score™ of 59/100 and a GF Value™ of $26.50 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 705 Medical Devices & Instruments companies, Meihua International Medical Technologies Co ranks better than 80.28% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
MHUAF's Debt-to-Equity is ranked better than 80.28% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs MHUAF: 0.05
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Meihua International Medical Technologies Co Debt-to-Equity Related Terms
Meihua International Medical Technologies Co Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co Debt-to-Equity Chart
Meihua International Medical Technologies Co Annual Data
MHUAF vs CUPR, LUCY, NXGL: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co Debt-to-Equity vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co (MHUAF) has a Debt-to-Equity of 0.05 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Meihua International Medical Technologies Co and its competitors. This is near median its historical median of 0.05. Over the past decade, Meihua International Medical Technologies Co's Debt-to-Equity has ranged from 0.04 to 0.05. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #139 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 19.7%.
Is Meihua International Medical Technologies Co's Debt-to-Equity too high?
Meihua International Medical Technologies Co's current Debt-to-Equity of 0.05 is near median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.05. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Meihua International Medical Technologies Co's value of 0.05 is 78.3% below this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #139 out of 705 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's Debt-to-Equity compare to CUPR and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #139 out of 705 companies for Debt-to-Equity. This places Meihua International Medical Technologies Co in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.23. Meihua International Medical Technologies Co's value of 0.05 is 78.3% below this benchmark. Historically, Meihua International Medical Technologies Co's own Debt-to-Equity has ranged from 0.04 to 0.05 over the past decade. While the company's 10-year median is 0.05 vs. the industry median of 0.23, Meihua International Medical Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current Debt-to-Equity of 0.05 is 78.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current Debt-to-Equity is 0.05, which is near median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $26.50, compared to a current price of $8.77 — trading 66.9% below its estimated fair value. The current Debt-to-Equity is 0.05, which is near median its 10-year median of 0.05 and 78.3% below the Medical Devices & Instruments industry median of 0.23. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current Debt-to-Equity is 0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $8.77 is trading 66.9% below its estimated GF Value™ of $26.50.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
Debt-to-Equity: 0.05 (near median its 10-year median of 0.05)
GF Value™: $26.50 vs. price of $8.77 (66.9% below fair value)
Industry Position: 78.3% below the Medical Devices & Instruments median (#139 of 705)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
